A Phase 1/2 Trial to Safety and Efficacy of investigational drug for Cervical Intraepithelial Neoplasia(CIN)
Latest Information Update: 16 Oct 2024
At a glance
- Drugs FIT 039 (Primary)
- Indications Cervical intraepithelial neoplasia
- Focus Adverse reactions; Pharmacokinetics
Most Recent Events
- 30 Jun 2022 New trial record
- 07 Jun 2022 Results presented at the 58th Annual Meeting of the American Society of Clinical Oncology